CLINICAL_TRIALS
trial_result
· 2024-04-25
Clinical Trial Update: Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery
Summary
An early feasibility study evaluating the AccuraSee device for correcting residual refractive errors after cataract surgery has completed, with results posted o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OnPoint Vision Inc | Conditions: Refractive Errors | Status: COMPLETED | Results posted: 2024-04-25